[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-460829-105":59,"doc-detail-460829-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prediction-scores-identifying-patients-at-high-risk-of-endocarditis-in-enterococcal-bacteremia","Prediction Scores - Identifying Patients at High Risk of Endocarditis in Enterococcal Bacteremia","","Clinical prediction scores such as NOVA and DENOVA are designed to identify patients with enterococcal bacteremia who are at low risk of infective endocarditis, allowing imaging to be deferred safely. A retrospective evaluation of adult patients from two Swiss tertiary centers (2015–2024) assessed performance of NOVA and DENOVA and introduced a modified DENOVi tool. Endocarditis Teams adjudicated IE using 2023 Duke-International Society criteria. Adapted thresholds stratified high risk, and results compared rule-out reliability and imaging resource use.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prediction-scores-identifying-patients-at-high-risk-of-endocarditis-in-enterococcal-bacteremia/460829/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prediction-scores-identifying-patients-at-high-risk-of-endocarditis-in-enterococcal-bacteremia/460829.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study goal regarding NOVA and DENOVA scores?","Question",{"text":112,"@type":113},"To evaluate the performance of NOVA and DENOVA in enterococcal bacteremia and to introduce a modified tool, DENOVi.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study define and classify high risk for infective endocarditis?",{"text":117,"@type":113},"Patients were stratified as high risk using adapted NOVA (≥4), DENOVA (≥3), and DENOVi (≥2), with DENOVi excluding the subjective murmur criterion and expanding “valve disease” to include intracardiac electronic devices.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about safely ruling out infective endocarditis?",{"text":121,"@type":113},"Both adapted NOVA and DENOVi reliably ruled out IE, while DENOVi provided the most balanced approach between diagnostic safety and resource utilization.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},460829,1791007384,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Open Forum Infectious Diseases  \nMAJOR ARTICLE  \nPrediction Scores Identifying Patients at High Risk of Endocarditis in Enterococcal Bacteremia  \nVirgile Zimmermann,1, Nicolas Fourré,1, Bruno Ledergerber,2, Jana Epprecht,2, Pierre Monney,3, Georgios Tzimas,3, Michelle Frank,4 Laurence Senn,1,5 Nicoleta Ianculescu,3 Lars Niclauss,6, Matthias Kirsch,6, Mathias Van Hemelrijck,7, Omer Dzemali,7,8,9, Benoit Guery,1 Barbara Hasse,2,a, and Matthaios Papadimitriou-Olivgeris1,10,a,  \n1Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 2Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland, 3Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 4Department of Cardiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland, 5Infection Prevention and Control Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 6Department of Cardiac Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, 7Department of Cardiac Surgery, University Hospital Zurich and University of Zurich, Zurich, Switzerland, 8Department of Cardiac Surgery, City Hospital of Zurich—Triemli, Zurich, Switzerland, 9Center for Experimental and Translational Cardiology, University of Zurich, Zurich, Switzerland, and 10Infectious Diseases Service, Hospital of Valais and Institut Central des Hôpitaux, Sion, Switzerland  \nBackground. Clinical prediction scores such as NOVA and DENOVA aim to identify patients with enterococcal bacteremia at low risk of infective endocarditis (IE) in whom imaging might be safely avoided. The aim was to evaluate the performance of NOVA and DENOVA scores and to introduce a modified tool, DENOVi.  \nMethod. This retrospective study included adult patients with enterococcal bacteremia at 2 Swiss tertiary centers (2015–2024) . IE was adjudicated by multidisciplinary Endocarditis Teams according to 2023 Duke-International Society of Cardiovascular Infectious Diseases criteria. Patients were stratified as high risk for IE using the adapted NOVA score (cutoff: ≥4), the DENOVA score (≥3), and a newly developed DENOVi score (≥2), which excluded the subjective murmur criterion and broadened “valve disease” to include intracardiac electronic devices (new Vi component) .  \nResults. Among 827 bacteremia episodes, 172 (21%) were diagnosed with IE. The adapted NOVA, DENOVA, and DENOVi scores classified 76%, 26%, and 42% of patients as high risk, respectively. Corresponding NLRs were 0.04 (95% CI, .01–.15), 0.10 (0.06–0.16), and 0.04 (0.02–0.10) . The adapted NOVA substantially increased the proportion of echocardiograms needed to be performed from 58% based on clinical evaluation alone to 76%, whereas the DENOVA and DENOVi scores would have reduced this proportion to 26% and 42% of episodes, respectively.  \nConclusions. Both adapted NOVA and DENOVi scores reliably ruled out IE, but DENOVi provided the most balanced approach between diagnostic safety and resource utilization. DENOVi therefore represents a pragmatic and objective tool for IE risk stratification in enterococcal bacteremia. Prospective validation is warranted.  \nKeywords. enterococci; Enterococcus faecalis; infective endocarditis; NOVA score; predictive score.  \nEnterococci, particularly Enterococcus faecalis, are among the leading bacterial causes of infective endocarditis (IE) [ 1–3] . IE due to enterococci is associated with substantial morbidity and mortality, especially in older patients and in individuals with predisposing cardiac conditions or implanted devices. With the rising prevalence of intracardiac electronic devices and transcatheter valve interventions, the incidence of enterococcal IE has further increased [ 1, 4]. This is partly attributable to the fact that these procedures are predominantly performed in elderly pa","cbCaivSEhBjYTqnw","https://ap.wps.com/l/cbCaivSEhBjYTqnw","pdf",379517,"English","# Background\n# Method\n## Study design and risk stratification\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What was the study goal regarding NOVA and DENOVA scores?\",\"answer\":\"To evaluate the performance of NOVA and DENOVA in enterococcal bacteremia and to introduce a modified tool, DENOVi.\"},{\"question\":\"How did the study define and classify high risk for infective endocarditis?\",\"answer\":\"Patients were stratified as high risk using adapted NOVA (≥4), DENOVA (≥3), and DENOVi (≥2), with DENOVi excluding the subjective murmur criterion and expanding “valve disease” to include intracardiac electronic devices.\"},{\"question\":\"What were the key findings about safely ruling out infective endocarditis?\",\"answer\":\"Both adapted NOVA and DENOVi reliably ruled out IE, while DENOVi provided the most balanced approach between diagnostic safety and resource utilization.\"}]","Prediction Scores - Identifying Patients at High Risk of Endocarditis in Enterococcal Bacteremia | PDF",1790759751,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/c9324d6b33095c98e06637c7f80ddb9c.webp",983,1296,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/939fd71146cdb9aa0f56e8a848e8b42b.webp",982,1294,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/bf60959c40a9a4ee2a83a46a94011190.webp",981,1293,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/aa5a69916c124d52a847464d6347f9f4.webp",980,1292]